Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNon-alcoholic fatty liver disease: what the clinician needs to know.Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentCholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseGender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetesRelationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults.Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c.Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort.Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucoseIncreased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetesLiver and diabetes. A vicious circle.Non-alcoholic fatty liver disease and diabetes.The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels.Physical activity for the prevention and treatment of metabolic disorders.Non-alcoholic fatty liver disease: factors associated with its presence and onset.Management of fatty liver disease with the metabolic syndrome.Blood pathway analyses reveal differences between prediabetic subjects with or without dyslipidaemia. The Cardiovascular Risk in Young Finns Study.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study.Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.Combined low-saturated fat intake and high fitness may counterbalance diabetogenic effects of obesity: the DR's EXTRA Study.Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.Sirtuin 6, a possible therapeutic target for type 2 diabetes.Fatty liver disease, glucose tolerance and insulin resistance in obese adolescents.The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients.Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
P2860
Q22299426-6BE53874-4AC3-4EC7-9718-B43F078FA896Q24563068-222946EC-C5C5-499B-9233-2E95A544B0FCQ24658538-BBC198F4-F410-4DF3-B8D4-AD5490B246B3Q26852019-B46F641B-A778-4136-8760-D38BA74A8C01Q30410638-59336A22-1195-4003-8EAD-84F0F2AE696AQ33607697-DA4D456C-5090-4F55-ACBC-8395DD5A1273Q33892867-2A1EB762-3304-48D3-BFB9-7A0BC5BAB307Q34029988-4C2D7892-4035-4C76-A4FA-96ACA7C78B75Q34460342-2AD4E9E1-8A16-4727-BD7D-DCC912BF3AAAQ35258097-0BF7B4B2-C714-4B11-A94A-ADD95EA8ADE4Q36334120-01E6E9AC-C43D-4AE0-B236-628E2E6ABACDQ36637911-7E2D879C-C987-4AA3-80CE-9072A1E32EBEQ36796925-E6A97141-DD08-4FCF-A519-31D17AB39972Q36800168-032FC639-E2C1-4DC2-BF52-6B142EFF501DQ37060889-6B1FE23B-EA8C-4B8D-80EE-38EABE41A319Q37070333-FB109F6E-C14C-4A57-821E-1620B371ADC3Q37091659-E31BEBDE-3C4F-41BF-897C-416CC3748B37Q37110166-C51BFF13-D641-43A9-8D50-9DFD14910912Q37555942-B4F8B02E-950E-4E5E-A4F1-0A2CF79B0245Q38105296-17EB0A0F-5126-48CC-B768-785A38C3AEA2Q38164074-B54AA77B-58D9-4A62-A0D0-9062BC09A5FFQ38199130-C89AF3D7-B006-417B-AFE8-EA935D3B14BEQ38727721-EE4B3F58-E49E-45B0-B93F-D39DF97C0AAFQ38859044-7310FC71-8FE0-4F8E-B39A-2DF59F483789Q39017557-AC13AFF3-83B4-4513-AFB9-CA276298C0AAQ39410610-DAFB1D63-80E0-47AA-8902-46BA5037512FQ39508242-3334F05F-6340-4A3F-87D2-642804A729A0Q40724787-9445DFFE-D130-4F35-B1A5-C6F9BC14D1EDQ41710966-47100778-E2BA-4B56-9D77-CDA26CA87049Q44222140-F2CCF274-0CE9-4BBD-94A9-6C08835C0C1FQ44530645-BB84C95E-2EC8-40B3-ABB8-AA14DCB7DC30Q46962933-542189A9-B174-427C-ABA3-4105B6C470ABQ47156332-4E2BA629-FFCB-4CD2-B8CA-8BEB46DB2DB2Q49608860-8F0469DF-D450-4A6F-94E5-1EECE580B57CQ50992764-D25B10C4-857C-4F39-A975-BE39876911FDQ51266115-690EA86E-8635-483F-B939-2E2054284062Q51282142-E1E91523-9FED-4B88-AAC7-C54D4F5B0DF4Q52843844-9998F279-6F98-4265-BD8A-B83B51BFF5A8Q54968743-B0D8B30A-FDE8-4CA0-B1AB-164D210E7566Q55326372-0EE5BC83-322F-4D36-9642-B03C910A8DA5
P2860
Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combined effect of nonalcoholi ...... trospective longitudinal study
@ast
Combined effect of nonalcoholi ...... trospective longitudinal study
@en
Combined effect of nonalcoholi ...... trospective longitudinal study
@nl
type
label
Combined effect of nonalcoholi ...... trospective longitudinal study
@ast
Combined effect of nonalcoholi ...... trospective longitudinal study
@en
Combined effect of nonalcoholi ...... trospective longitudinal study
@nl
prefLabel
Combined effect of nonalcoholi ...... trospective longitudinal study
@ast
Combined effect of nonalcoholi ...... trospective longitudinal study
@en
Combined effect of nonalcoholi ...... trospective longitudinal study
@nl
P2093
P2860
P356
P1433
P1476
Combined effect of nonalcoholi ...... trospective longitudinal study
@en
P2093
Cheol Young Park
Ji Cheol Bae
Se Eun Park
Sun Woo Kim
Sung Woo Park
P2860
P304
P356
10.2337/DC10-1991
P407
P577
2011-01-28T00:00:00Z